ALK gene rearrangements are mutually exclusive with all other known thyroid cancer driver mutations and have been reported in up to 2.2 % of PTCs, 4 % of poorly differentiated carcinomas, and 4 % of anaplastic carcinomas [26, 28, 32]. Here, ALK is linked to thyroid gland carcinoma.